This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novotyr Therapeutics Ltd.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Lilach Steiner: Innovator in Protein Kinase Modulation
Introduction
Lilach Steiner is a prominent inventor based in Mevaseret Zion, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting protein kinases. Her innovative work has the potential to impact the treatment of various disorders, including cancer and psoriasis.
Latest Patents
Lilach Steiner holds a patent for "Protein kinase modulators and therapeutic uses thereof." This invention provides new tyrphostin derivatives that act as substrate competitive protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors. The patent outlines methods for the preparation of these compounds, pharmaceutical compositions that include them, and their applications as chemotherapeutic agents for the prevention and treatment of PTK and RTK related disorders, such as metabolic, fibrotic, and cell proliferative disorders.
Career Highlights
Steiner is associated with Novotyr Therapeutics Ltd., where she continues to advance her research and development efforts. Her work focuses on creating innovative solutions that address critical health challenges. With her expertise, she has positioned herself as a key player in the biotechnology sector.
Collaborations
Lilach collaborates with talented professionals in her field, including Iris Ben-David and Hadas Reuveni. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Lilach Steiner's contributions to the field of protein kinase modulation exemplify her commitment to advancing medical science. Her innovative patent and collaborative efforts position her as a significant figure in biotechnology.